These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34591289)

  • 1. The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer.
    Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E
    Breast Cancer; 2022 Mar; 29(2):209-215. PubMed ID: 34591289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.
    Noguchi M; Noguchi M; Ohno Y; Morioka E; Nakano Y; Kosaka T; Kurose N; Minato H
    Eur J Surg Oncol; 2016 May; 42(5):650-6. PubMed ID: 27005806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy.
    Tasdoven I; Balbaloglu H; Erdemir RU; Bahadir B; Guldeniz Karadeniz C
    Medicine (Baltimore); 2022 Dec; 101(52):e32545. PubMed ID: 36596061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is axillary reverse mapping feasible in breast cancer patients?
    Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
    Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
    Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
    World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal.
    Cebrecos I; Mension E; Alonso I; Castillo H; Sanfeliu E; Vidal-Sicart S; Ganau S; Vidal M; Schettini F
    Ann Surg Oncol; 2023 Aug; 30(8):4657-4668. PubMed ID: 36809608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    Foster D; Choy N; Porter C; Ahmed S; Wapnir I
    J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
    Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Kuerer HM; Bowling M; Flippo-Morton TS; Byrd DR; Ollila DW; Julian TB; McLaughlin SA; McCall L; Symmans WF; Le-Petross HT; Haffty BG; Buchholz TA; Nelson H; Hunt KK;
    JAMA; 2013 Oct; 310(14):1455-61. PubMed ID: 24101169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
    Fan YJ; Li JC; Zhu DM; Zhu HL; Zhao Y; Zhu XB; Wu G; Bai TT
    BMC Surg; 2023 Jul; 23(1):209. PubMed ID: 37495945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative axillary surgery is emerging in the surgical management of breast cancer.
    Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E; Haba Y
    Breast Cancer; 2023 Jan; 30(1):14-22. PubMed ID: 36342647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
    Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
    Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.
    Connor C; McGinness M; Mammen J; Ranallo L; Lafaver S; Klemp J; Fan F; Mahnken J
    Ann Surg Oncol; 2013 Oct; 20(10):3303-7. PubMed ID: 23975287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.
    Noguchi M; Inokuchi M; Noguchi M; Morioka E; Kurita T
    Eur J Surg Oncol; 2020 Dec; 46(12):2218-2220. PubMed ID: 32912671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary reverse mapping using a fluorescence imaging system in breast cancer.
    Noguchi M; Noguchi M; Nakano Y; Ohno Y; Kosaka T
    J Surg Oncol; 2012 Mar; 105(3):229-34. PubMed ID: 21913193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis.
    Petousis S; Christidis P; Margioula-Siarkou C; Liberis A; Vavoulidis E; Margioula-Siarkou G; Vatopoulou A; Papanikolaou A; Mavromatidis G; Dinas K
    Arch Gynecol Obstet; 2022 Oct; 306(4):1221-1234. PubMed ID: 35249123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
    Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
    J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary surgery for breast cancer: past, present, and future.
    Noguchi M; Inokuchi M; Noguchi M; Morioka E; Ohno Y; Kurita T
    Breast Cancer; 2021 Jan; 28(1):9-15. PubMed ID: 33165758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
    Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C
    Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.